We found that RU.521 attenuated PD‐related behavior phenotypes, reduced the loss of TH‐positive neurons, decreased the number of activated microglial cells in the SN, and lowered levels in factors associated with cGAS‐dependent inflammation (Figure 7B–G). This evidence concerns the gene CGAS and Parkinson disease.